74 related articles for article (PubMed ID: 20460948)
1. Increased postprandial response of glucagon-like peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
Hornum M; Pedersen JF; Larsen S; Olsen O; Holst JJ; Knop FK
Pancreatology; 2010; 10(2-3):201-7. PubMed ID: 20460948
[TBL] [Abstract][Full Text] [Related]
2. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.
Knop FK; Vilsbøll T; Larsen S; Højberg PV; Vølund A; Madsbad S; Holst JJ; Krarup T
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E324-30. PubMed ID: 16954337
[TBL] [Abstract][Full Text] [Related]
3. Incretin hormones and beta cell function in chronic pancreatitis.
Knop FK
Dan Med Bull; 2010 Jul; 57(7):B4163. PubMed ID: 20591345
[TBL] [Abstract][Full Text] [Related]
4. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M
JOP; 2010 Sep; 11(5):489-91. PubMed ID: 20818126
[No Abstract] [Full Text] [Related]
5. The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients.
Bremholm L; Hornum M; Andersen UB; Hartmann B; Holst JJ; Jeppesen PB
Regul Pept; 2011 Jun; 168(1-3):32-8. PubMed ID: 21421014
[TBL] [Abstract][Full Text] [Related]
6. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T
Regul Pept; 2007 Dec; 144(1-3):123-30. PubMed ID: 17692937
[TBL] [Abstract][Full Text] [Related]
7. GLP-2 and mesenteric blood flow.
Hansen LB
Dan Med J; 2013 May; 60(5):B4634. PubMed ID: 23673268
[TBL] [Abstract][Full Text] [Related]
8. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
[TBL] [Abstract][Full Text] [Related]
9. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
[TBL] [Abstract][Full Text] [Related]
10. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
Toft-Nielsen M; Madsbad S; Holst JJ
Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
[TBL] [Abstract][Full Text] [Related]
11. Lower glucose-dependent insulinotropic polypeptide (GIP) response but similar glucagon-like peptide 1 (GLP-1), glycaemic, and insulinaemic response to ancient wheat compared to modern wheat depends on processing.
Bakhøj S; Flint A; Holst JJ; Tetens I
Eur J Clin Nutr; 2003 Oct; 57(10):1254-61. PubMed ID: 14506486
[TBL] [Abstract][Full Text] [Related]
12. Duplex ultrasound of the superior mesenteric artery in chronic pancreatitis.
Hornum M; Larsen S; Olsen O; Pedersen JF
Br J Radiol; 2006 Oct; 79(946):804-7. PubMed ID: 16822799
[TBL] [Abstract][Full Text] [Related]
13. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves.
Taylor-Edwards CC; Burrin DG; Holst JJ; McLeod KR; Harmon DL
J Dairy Sci; 2011 Feb; 94(2):888-98. PubMed ID: 21257057
[TBL] [Abstract][Full Text] [Related]
15. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
Ranganath LR; Beety JM; Morgan LM
Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes.
Christensen M; Knop FK; Vilsbøll T; Aaboe K; Holst JJ; Madsbad S; Krarup T
Regul Pept; 2010 Aug; 163(1-3):96-101. PubMed ID: 20580750
[TBL] [Abstract][Full Text] [Related]
18. Role of gastrointestinal hormones in postprandial reduction of bone resorption.
Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; Krarup T; Holst JJ; Christiansen C
J Bone Miner Res; 2003 Dec; 18(12):2180-9. PubMed ID: 14672353
[TBL] [Abstract][Full Text] [Related]
19. Meal frequency; does it determine postprandial lipaemia?
Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
[TBL] [Abstract][Full Text] [Related]
20. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]